Christophe Roumier researcher
Roumier, Christophe, 1964-....
VIAF ID: 303508921 (Personal)
Permalink: http://viaf.org/viaf/303508921
Preferred Forms
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Application de la cytométrie en flux multiparamétrique au diagnostic des localisations cérébrales primitives ou secondaires des néoplasies lymphoïdes B matures à partir des profils cellulaire et cytokinique du liquide céphalorachidien | |
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study | |
C/EBPA methylation is common in T-ALL but not in M0 AML. | |
CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder | |
CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells | |
Etude des altérations de l’hématopoïèse dans les syndromes myélodysplasiques en cytométrie en flux multiparamétrique | |
ETUDE DES REARRANGEMENTS DU GENE LAZ3 DANS LES LYMPHOMES MALINS NON HODGKINIENS PAR HYBRIDATION IN SITU DE SONDES FLUORESCENTES (FISH) (DES BIOL. MED.) | |
Expression de la protéine B7-H3 et impact pronostique dans les leucémies aiguës myéloïdes | |
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up | |
Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia. | |
Genomic characterization of Imatinib resistance in CD34+ cell populations from chronic myeloid leukaemia patients | |
Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms | |
IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association | |
Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission. | |
Involvement of a common progenitor cell in core binding factor acute myeloid leukaemia associated with mastocytosis | |
LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis. | |
M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH) | |
Mise en place du suivi de la maladie résiduelle des LAL-T par cytométrie en flux multiparamétrique | |
MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome | |
Paroxysmal nocturnal hemoglobinuria (PNH) and T cell large granular lymphocyte (LGL) leukemia--an unusual association: another cause of cytopenia in PNH | |
Role of multiplex FISH in identifying chromosome involvement in myelodysplastic syndromes and acute myeloid leukemias with complex karyotypes: a report on 28 cases | |
Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemia. | |
TP53 mutation and its prognostic significance in Waldenstrom's Macroglobulinemia | |
Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis | |
Unlike AML1, CBFbeta gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromes |